<DOC>
	<DOCNO>NCT01394055</DOCNO>
	<brief_summary>The purpose study evaluate pharmacodynamic ( PD ) pharmacokinetic ( PK ) profile safety tolerability RM-131 patient diabetes mellitus delay gastric emptying .</brief_summary>
	<brief_title>Study Assess Pharmacodynamics RM-131 Patients With Diabetic Gastroparesis</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Diabetes Complications</mesh_term>
	<criteria>Key Able provide write informed consent prior study procedure . Diagnosis Type 1 2 diabetic gastroparesis . Controlled Type 1 2 diabetes mellitus ( HbA1c &lt; 10.1 % ) . Stable concomitant medication define change regimen least 2 week prior Period 1 ( daily adjustment insulin dos permit ) . Body mass index 1840 kg/mÂ² . Key Unable unwilling provide inform consent comply study procedure . History gastric surgery fundoplication , gastrectomy , gastric pacemaker placement , vagotomy , bariatric procedure . ( Note : history diagnostic endoscopy exclusionary ) . Acute chronic illness history illness , opinion Investigator , could pose threat harm patient obscure interpretation laboratory test result interpretation study data frequent angina , Class III IV congestive heart failure , poor renal hepatic function , etc . Any clinically significant abnormality screen laboratory determine Investigator . Abnormal 12lead electrocardiogram ( ECG ) , include evidence acute myocardial subendocardial ischemia clinically significant arrhythmias conduction abnormality blood pressure screen except minor deviation deem clinical significance Investigator . Poor venous access inability tolerate venipuncture . Acute GI illness within 48 hour Period 1 . Positive pregnancy test . Participation clinical study within 30 day prior dose present study . Any reason , opinion Investigator , would confound proper interpretation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Diabetes Mellitus Type 1 2</keyword>
	<keyword>Delayed Gastric Emptying</keyword>
	<keyword>Gastroparesis</keyword>
	<keyword>Gastrointestinal Motility Disorder</keyword>
</DOC>